(UroToday.com) While conventional staging studies remain the standard of care, PSMA testing will likely drastically change the landscape of prostate cancer evaluation, as it is clearly more sensitive than conventional imaging. Intraprostatic PSMA intensity, as measured by standardized uptake values (SUV), are potentially associated with clinically relevant oncological outcomes for prostate cancer.